Layer, Chiang, et al. Genome Biology
Silence Inks siRNA-Delivery Deal with Dainippon Sumitomo Pharma
Under the terms of the deal, Silence will “demonstrate the functional delivery” of its proprietary siRNA molecules, in combination with its in-house AtuPlex delivery technology, to certain undisclosed targets.
New to GenomeWeb? Register here quickly.